Protalix Biotherapeutics, Inc. (PLX)
3.06
-0.09
(-2.86%)
USD |
NYAM |
Feb 20, 16:00
3.06
0.00 (0.00%)
Pre-Market: 20:00
Protalix Biotherapeutics Market Cap : 246.09M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 3.153B |
| OraSure Technologies, Inc. | 197.27M |
| Nephros, Inc. | 43.36M |
| Agenus, Inc. | 110.59M |
| Curis, Inc. | 14.35M |
Market Cap Related Metrics
| PE Ratio | 44.03 |
| PS Ratio | 3.891 |
| Price to Book Value | 4.651 |
| Price | 3.06 |
| Earnings Yield | 2.27% |
| Operating PE Ratio | 37.79 |
| Normalized PE Ratio | 44.03 |